Antiviral Effect of Retro-2.1 against Herpes Simplex Virus Type 2 In Vitro. 2018

Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, P.R. China.

Herpes simplex virus type 2 (HSV-2) infection has been a public health concern worldwide. It is the leading cause of genital herpes and a contributing factor to cervical cancer and human immunodeficiency virus (HIV) infection. No vaccine is available yet for the treatment of HSV-2 infection, and routinely used synthetic nucleoside analogs have led to the emergence of drug resistance. The small molecule Retro-2cycl has been reported to be active against several pathogens by acting on intracellular vesicle transport, which also participates in the HSV-2 lifecycle. Here, we showed that Retro-2.1, which is an optimized, more potent derivative of Retro-2cycl, could inhibit HSV-2 infection, with 50% inhibitory concentrations of 5.58 μM and 6.35 μM in cytopathic effect inhibition and plaque reduction assays, respectively. The cytotoxicity of Retro-2.1 was relatively low, with a 50% cytotoxicity concentration of 116.5 μM. We also preliminarily identified that Retro-2.1 exerted the antiviral effect against HSV-2 by a dual mechanism of action on virus entry and late stages of infection. Therefore, our study for the first time demonstrated Retro-2.1 as an effective antiviral agent against HSV-2 in vitro with targets distinct from those of nucleoside analogs.

UI MeSH Term Description Entries
D010948 Viral Plaque Assay Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE. Bacteriophage Plaque Assay,Assay, Bacteriophage Plaque,Assay, Viral Plaque,Assays, Bacteriophage Plaque,Assays, Viral Plaque,Bacteriophage Plaque Assays,Plaque Assay, Bacteriophage,Plaque Assay, Viral,Plaque Assays, Bacteriophage,Plaque Assays, Viral,Viral Plaque Assays
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001549 Benzamides BENZOIC ACID amides.
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell
D018258 Herpesvirus 2, Human A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact. HSV-2,Herpes Simplex Virus 2,Human Herpesvirus 2,HHV-2,Herpes Simplex Virus Type 2,Herpesvirus 2 (alpha), Human
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
September 1993, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
January 1992, Archives of virology,
Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
June 2023, Biotechnology reports (Amsterdam, Netherlands),
Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
April 2009, International journal of molecular medicine,
Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
February 2002, Journal of medical virology,
Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
December 2002, Antiviral research,
Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
January 2004, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
October 2019, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
July 1976, Antimicrobial agents and chemotherapy,
Wen Dai, and Yu Wu, and Jin Bi, and Jing Wang, and Shuai Wang, and Wei Kong, and Julien Barbier, and Jean-Christophe Cintrat, and Feng Gao, and Zheng Jiang, and Daniel Gillet, and Wei Su, and Chun Jiang
March 1992, Bioscience, biotechnology, and biochemistry,
Copied contents to your clipboard!